Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic
  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Central Garden & Pet Announces Q4 and Fiscal 2022 Financial Results

Fiscal 2022 net sales increased 1% to $3.3 billion

Fiscal 2022 diluted EPS increased 2% to $2.80

Initial outlook for fiscal 2023 EPS in the range of $2.60 to $2.80

Central Garden & Pet Company (NASDAQ: CENT) (NASDAQ: CENTA) ("Central"), a market leader in the Garden and Pet industries, today announced results for its fourth quarter and fiscal year 2022 ended September 24, 2022.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221121005727/en/

Central Garden & Pet delivers solid FY 2022 results in a challenging macroeconomic environment (Graphic: Business Wire)

Central Garden & Pet delivers solid FY 2022 results in a challenging macroeconomic environment (Graphic: Business Wire)

"Central delivered solid fiscal 2022 results in a challenging environment characterized by poor weather during the peak garden season, high inflation, evolving consumer behavior and unfavorable retailer inventory dynamics. Despite these headwinds, we grew net sales, gross margin, operating income, and EPS versus prior year, and we exceeded the guidance we provided in June," said Tim Cofer, CEO of Central Garden & Pet. "While the near-term economic outlook remains volatile and likely unfavorable, we remain confident in the fundamental trends that support growth in the Garden and Pet industries, the competitive strength of Central and our Central to Home strategy."

Fiscal 2022 Results

Net sales were $3.3 billion, an increase of 1% compared to the prior year, driven by the Company's recent acquisitions. Net sales grew at a 12% three-year CAGR from $2.4 billion in fiscal 2019. Organic net sales decreased 3%.

Net sales for the Pet segment were $1.9 billion, a decrease of 1% compared to a year ago, unfavorably impacted by SKU rationalization and the purposeful decision to exit low-profit private label product lines. Net sales for the Pet segment grew at a 9% three-year CAGR compared to $1.5 billion in fiscal 2019. Net sales for the Garden segment increased 4% to $1.5 billion compared to $1.4 billion in the prior year and at a 17% three-year CAGR compared to $923 million in fiscal 2019.

Despite significant inflationary headwinds across commodities, freight and labor, gross margin increased 30 basis points to 29.7% compared to 29.4% a year ago. The Company was able to offset these headwinds through a combination of pricing actions, favorable product mix and gross productivity efforts.

Operating income of $260 million increased 2% from $254 million in fiscal 2021. Operating margin increased 10 basis points to 7.8% compared to 7.7% a year ago, due to gross margin improvement.

Other expense was $3.6 million compared to $1.5 million in the prior year.

Net interest expense was $58 million, in line with the prior year.

Net income was $152 million, in line with a year ago. Diluted earnings per share grew $0.05 to $2.80 compared to $2.75 in the prior year.

Adjusted EBITDA was $367 million, an increase of 4% compared to $352 million in fiscal 2021.

The effective tax rate for the fiscal year was 23.2% compared to 21.6% in the prior year. The increased effective income tax rate in fiscal 2022 was due primarily to a reduced tax benefit from stock-based compensation compared to the prior year.

Fourth Quarter Fiscal 2022 Results

Net sales decreased 4% to $707 million compared to $739 million in the fourth quarter of fiscal 2021.

Gross margin decreased 60 basis points to 28.2% as the positive effect of pricing actions was more than offset by substantial inflationary cost pressure and lower sales volume.

Operating income was $13 million, an increase of 34% compared to $10 million in the fourth quarter of fiscal 2021. Operating margin was 1.8%, an increase of 50 basis points compared to 1.3% in the prior year quarter.

Other expense was $2.3 million compared to $1.9 million in the fourth quarter of fiscal 2021.

Net interest expense of $14 million for the fourth quarter was in line with the prior-year quarter.

This resulted in a net loss of $2.0 million compared to a net loss of $3.0 million in the fourth quarter of fiscal 2021, and a diluted loss per share of $0.04 compared to a diluted loss per share of $0.06 in the prior year quarter.

Adjusted EBITDA was $42 million, up 13% from $38 million in the fourth quarter of fiscal 2021.

Pet Segment Fourth Quarter Fiscal 2022 Results

Net sales for the Pet segment were $440 million, a decrease of 4% compared to the prior year, unfavorably impacted by SKU rationalization and the purposeful decision to exit low-profit private label product lines.

The Pet segment’s operating income was $40 million, an increase of 28% compared to $32 million in the prior year quarter. Operating margin of 9.2% reflected an increase of 230 basis points compared to 6.9% in the fourth quarter of fiscal 2021, driven primarily by lower commercial expense and variable compensation as well as the favorable impact of pricing actions.

Garden Segment Fourth Quarter Fiscal 2022 Results

Net sales for the Garden segment were $268 million, a decrease of 4% compared to the prior year quarter, due to softness across most of the Garden portfolio, partially offset by continued strength in wild bird, packet seeds and grass seed.

The Garden segment’s operating income was $1.8 million compared to $1.1 million in the fourth quarter of fiscal 2021. Operating margin was 0.7%, an increase of 30 basis points compared to 0.4% in the prior year quarter, driven by lower variable compensation compared to the prior year.

Additional Information

At September 24, 2022, the Company’s cash and cash equivalents was $177 million, compared to $426 million a year ago.

Cash used by operations for fiscal 2022 was $34 million, compared to cash provided by operations of $251 million in the prior year. The increase in cash used by operations was primarily due to changes in working capital driven in part by the higher cost of inventory in this inflationary environment as well as management's decision to increase inventory levels significantly to mitigate the adverse impact of supply chain disruptions on the Company's fill rates.

Total debt at September 24, 2022 and September 25, 2021 was $1.2 billion. The Company's leverage ratio, as defined in the Company's credit agreement, at the end of the quarter and the fiscal year was 2.9x compared to 3.0x in the prior year. The Company repurchased approximately 495 thousand shares or $20 million of its stock during the quarter.

Outlook for Fiscal 2023

The Company currently projects fiscal 2023 GAAP EPS in the range of $2.60 to $2.80. This outlook reflects the macroeconomic uncertainty, further cost inflation, evolving consumer behavior and unfavorable retailer inventory dynamics. The outlook includes anticipated pricing actions and productivity initiatives across the Company's portfolio to help mitigate inflationary headwinds. The Company expects fiscal 2023 capital spending to be significantly below fiscal 2022 levels. Fiscal 2023 will have 53 weeks compared to 52 weeks in fiscal 2022. This outlook does not include the impact of any acquisitions that may close during fiscal 2023.

Conference Call

The Company will host a conference call today at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss its fourth quarter and fiscal year 2022 results. The conference call and related materials can be accessed at http://ir.central.com.

Alternatively, to listen to the call by telephone, dial (201) 689-8345 (domestic and international) using confirmation #13732255.

About Central Garden & Pet

Central Garden & Pet Company (NASDAQ: CENT) (NASDAQ: CENTA) understands that home is central to life and has proudly nurtured happy and healthy homes for over 40 years. With fiscal 2022 net sales of $3.3 billion, Central is on a mission to lead the future of the Pet and Garden industries. The Company’s innovative and trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a leading portfolio of more than 65 high-quality brands including Amdro®, Aqueon®, Cadet®, Farnam®, Ferry~Morse®, Four Paws®, Kaytee®, K&H®, Nylabone® and Pennington®, strong manufacturing and distribution capabilities and a passionate, entrepreneurial growth culture. Central Garden & Pet is based in Walnut Creek, California and has over 7,000 employees across North America and Europe. Visit www.central.com to learn more.

Safe Harbor Statement

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this release which are not historical facts, including further cost inflation, evolving consumer behavior and unfavorable retailer dynamics, anticipated pricing actions, productivity initiatives and reduced capital spending, and earnings guidance for fiscal year 2023, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by forward-looking statements. All forward-looking statements are based upon the Company’s current expectations and various assumptions. There are a number of risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements contained in this release including, but not limited to, the following factors:

  • high inflation, a potential recession and other adverse macro-economic conditions;
  • fluctuations in market prices for seeds and grains and other raw materials;
  • our inability to pass through cost increases in a timely manner;
  • fluctuations in energy prices, fuel and related petrochemical costs;
  • declines in consumer spending and increased inventory risk during economic downturns;
  • our ability to successfully manage the continuing impact of COVID-19 on our business, including but not limited to, the impact on our workforce, operations, fill rates, supply chain, demand for our products and services, and our financial results and condition;
  • the potential for future reductions in demand for product categories that benefited from the COVID-19 pandemic, including the potential for reduced orders as retailers work through excess inventory;
  • adverse weather conditions;
  • the success of our Central to Home strategy;
  • risks associated with our acquisition strategy, including our ability to successfully integrate acquisitions and the impact of purchase accounting on our financial results;
  • supply chain delays and disruptions resulting in lost sales, reduced fill rates and service levels and delays in expanding capacity and automating processes;
  • seasonality and fluctuations in our operating results and cash flow;
  • supply shortages in pet birds, small animals and fish;
  • dependence on a small number of customers for a significant portion of our business;
  • consolidation trends in the retail industry;
  • risks associated with new product introductions, including the risk that our new products will not produce sufficient sales to recoup our investment;
  • competition in our industries;
  • continuing implementation of an enterprise resource planning information technology system;
  • potential environmental liabilities;
  • risk associated with international sourcing;
  • impacts of tariffs or a trade war;
  • access to and cost of additional capital;
  • potential goodwill or intangible asset impairment;
  • our dependence upon our key executives;
  • our ability to recruit and retain new members of our management team to support our growing businesses and to hire and retain employees;
  • our inability to protect our trademarks and other proprietary rights;
  • litigation and product liability claims;
  • regulatory issues;
  • the impact of product recalls;
  • potential costs and risks associated with actual or potential cyber attacks;
  • potential dilution from issuance of authorized shares;
  • the voting power associated with our Class B stock; and
  • the impact of new accounting regulations and the possibility our effective tax rate will increase as a result of future changes in the corporate tax rate or other tax law changes.

These risks and others are described in the Company’s Securities and Exchange Commission filings. The Company undertakes no obligation to publicly update these forward-looking statements to reflect new information, subsequent events or otherwise.

CENTRAL GARDEN & PET COMPANY

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

(unaudited)

 

ASSETS

 

September 24, 2022

 

September 25, 2021

Current assets:

 

 

 

 

Cash and cash equivalents

 

$

177,442

 

 

$

426,422

 

Restricted cash

 

 

14,742

 

 

 

13,100

 

Accounts receivable, net

 

 

376,787

 

 

 

385,384

 

Inventories, net

 

 

938,000

 

 

 

685,237

 

Prepaid expenses and other

 

 

46,883

 

 

 

33,514

 

Total current assets

 

 

1,553,854

 

 

 

1,543,657

 

 

 

 

 

 

Plant, property and equipment, net

 

 

396,979

 

 

 

328,571

 

Goodwill

 

 

546,436

 

 

 

369,391

 

Other intangible assets, net

 

 

543,210

 

 

 

134,431

 

Operating lease right-of-use assets

 

 

186,344

 

 

 

165,602

 

Other assets

 

 

55,179

 

 

 

575,028

 

Total

 

$

3,282,002

 

 

$

3,116,680

 

 

 

 

 

 

LIABILITIES AND EQUITY

 

 

 

 

Current liabilities:

 

 

 

 

Accounts payable

 

$

215,681

 

 

$

245,542

 

Accrued expenses

 

 

201,783

 

 

 

234,965

 

Current lease liabilities

 

 

48,111

 

 

 

40,731

 

Current portion of long-term debt

 

 

317

 

 

 

1,081

 

Total current liabilities

 

 

465,892

 

 

 

522,319

 

 

 

 

 

 

Long-term debt

 

 

1,186,245

 

 

 

1,184,683

 

Long-term lease liabilities

 

 

147,724

 

 

 

130,125

 

Deferred income taxes and other long-term obligations

 

 

147,429

 

 

 

56,012

 

 

 

 

 

 

Equity:

 

 

 

 

Common stock

 

 

113

 

 

 

113

 

Class A common stock

 

 

413

 

 

 

423

 

Class B stock

 

 

16

 

 

 

16

 

Additional paid-in capital

 

 

582,056

 

 

 

576,446

 

Retained earnings

 

 

755,253

 

 

 

646,082

 

Accumulated other comprehensive loss

 

 

(4,145

)

 

 

(831

)

Total Central Garden & Pet shareholders’ equity

 

 

1,333,706

 

 

 

1,222,249

 

Noncontrolling interest

 

 

1,006

 

 

 

1,292

 

Total equity

 

 

1,334,712

 

 

 

1,223,541

 

Total

 

$

3,282,002

 

 

$

3,116,680

 

CENTRAL GARDEN & PET COMPANY

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

(unaudited)

 

 

Three Months Ended

 

Fiscal Year Ended

 

September 24, 2022

 

September 25, 2021

 

September 24, 2022

 

September 25, 2021

Net sales

$

707,442

 

 

$

739,127

 

 

$

3,338,588

 

 

$

3,303,684

 

Cost of goods sold

 

507,751

 

 

 

526,356

 

 

 

2,346,283

 

 

 

2,332,783

 

Gross profit

 

199,691

 

 

 

212,771

 

 

 

992,305

 

 

 

970,901

 

Selling, general and administrative expenses

 

186,793

 

 

 

203,166

 

 

 

732,269

 

 

 

716,405

 

Operating income

 

12,898

 

 

 

9,605

 

 

 

260,036

 

 

 

254,496

 

Interest expense

 

(14,620

)

 

 

(14,269

)

 

 

(58,253

)

 

 

(58,597

)

Interest income

 

531

 

 

 

93

 

 

 

719

 

 

 

415

 

Other expense, net

 

(2,259

)

 

 

(1,876

)

 

 

(3,596

)

 

 

(1,506

)

Income (loss) before income taxes and noncontrolling interest

 

(3,450

)

 

 

(6,447

)

 

 

198,906

 

 

 

194,808

 

Income tax (benefit) expense

 

(1,085

)

 

 

(3,225

)

 

 

46,234

 

 

 

42,035

 

Net income (loss) including noncontrolling interest

 

(2,365

)

 

 

(3,222

)

 

 

152,672

 

 

 

152,773

 

Net income (loss) attributable to noncontrolling interest

 

(375

)

 

 

(215

)

 

 

520

 

 

 

1,027

 

Net income (loss) attributable to Central Garden & Pet Company

$

(1,990

)

 

$

(3,007

)

 

$

152,152

 

 

$

151,746

 

 

 

 

 

 

 

 

 

Net income (loss) per share attributable to Central Garden & Pet Company:

 

 

 

 

 

 

 

Basic

$

(0.04

)

 

$

(0.06

)

 

$

2.86

 

 

$

2.81

 

Diluted

$

(0.04

)

 

$

(0.06

)

 

$

2.80

 

 

$

2.75

 

 

 

 

 

 

 

 

 

Weighted average shares used in the computation of net income per share:

 

 

 

 

 

 

 

Basic

 

52,718

 

 

 

53,926

 

 

 

53,220

 

 

 

53,914

 

Diluted

 

52,718

 

 

 

53,926

 

 

 

54,425

 

 

 

55,248

 

CENTRAL GARDEN & PET COMPANY

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

 

Fiscal Year Ended

 

September 24, 2022

 

September 25, 2021

 

September 26, 2020

 

(in thousands)

Cash flows from operating activities:

 

 

 

 

 

Net income

$

152,672

 

 

$

152,773

 

 

$

121,520

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

Depreciation and amortization

 

80,948

 

 

 

74,727

 

 

 

55,359

 

Amortization of deferred financing costs

 

2,657

 

 

 

2,208

 

 

 

1,873

 

Non-cash lease expense

 

48,656

 

 

 

41,044

 

 

 

35,025

 

Stock-based compensation

 

25,817

 

 

 

23,127

 

 

 

18,982

 

Debt extinguishment costs

 

169

 

 

 

8,577

 

 

 

 

Loss on sale of business

 

 

 

 

2,611

 

 

 

 

Deferred income taxes

 

28,128

 

 

 

(14,744

)

 

 

(6,615

)

Loss (gain) on disposal of property, plant and equipment

 

131

 

 

 

(256

)

 

 

1,171

 

Asset impairments

 

 

 

 

 

 

 

3,566

 

Other

 

(779

)

 

 

4,716

 

 

 

4,675

 

Changes in assets and liabilities (excluding businesses acquired):

 

 

 

 

 

Receivables

 

7,004

 

 

 

69,135

 

 

 

(91,470

)

Inventories

 

(256,443

)

 

 

(132,170

)

 

 

27,351

 

Prepaid expenses and other assets

 

(6,031

)

 

 

13,370

 

 

 

4,683

 

Accounts payable

 

(31,209

)

 

 

24,583

 

 

 

52,047

 

Accrued expenses

 

(33,495

)

 

 

6,734

 

 

 

72,278

 

Other long-term obligations

 

(7,728

)

 

 

14,731

 

 

 

(83

)

Operating lease liabilities

 

(44,527

)

 

 

(40,322

)

 

 

(36,089

)

Net cash (used in) provided by operating activities

 

(34,030

)

 

 

250,844

 

 

 

264,273

 

Cash flows from investing activities:

 

 

 

 

 

Additions to property, plant and equipment

 

(115,205

)

 

 

(80,333

)

 

 

(43,055

)

Businesses acquired, net of cash acquired

 

 

 

 

(820,453

)

 

 

 

Proceeds from sale of business

 

 

 

 

2,400

 

 

 

 

Payments for investments

 

(27,818

)

 

 

(500

)

 

 

(4,439

)

Other investing activities

 

40

 

 

 

(473

)

 

 

(612

)

Net cash used in investing activities

 

(142,983

)

 

 

(899,359

)

 

 

(48,106

)

Cash flows from financing activities:

 

 

 

 

 

Repayments on revolving line of credit

 

 

 

 

(858,000

)

 

 

(200,000

)

Borrowings on revolving line of credit

 

 

 

 

858,000

 

 

 

200,000

 

Premium paid on extinguishment of debt

 

 

 

 

(6,124

)

 

 

 

Repayments of long-term debt

 

(1,096

)

 

 

(430,401

)

 

 

(113

)

Issuance of long-term debt

 

 

 

 

900,000

 

 

 

 

Repurchase of common stock, including shares surrendered for tax withholding

 

(62,287

)

 

 

(27,892

)

 

 

(59,129

)

Payments of contingent consideration

 

(216

)

 

 

(373

)

 

 

(227

)

Distribution to noncontrolling interest

 

(806

)

 

 

(606

)

 

 

(143

)

Payment of financing costs

 

(2,410

)

 

 

(14,129

)

 

 

(948

)

Net cash (used in) provided by financing activities

 

(66,815

)

 

 

420,475

 

 

 

(60,560

)

Effect of exchange rate changes on cash and equivalents

 

(3,510

)

 

 

1,165

 

 

 

89

 

Net (decrease) increase in cash, cash equivalents and restricted cash

 

(247,338

)

 

 

(226,875

)

 

 

155,696

 

Cash, cash equivalents and restricted cash at beginning of year

 

439,522

 

 

 

666,397

 

 

 

510,701

 

Cash, cash equivalents and restricted cash at end of year

$

192,184

 

 

$

439,522

 

 

$

666,397

 

Supplemental information:

 

 

 

 

 

Cash paid for interest

$

57,928

 

 

$

42,762

 

 

$

43,892

 

Cash paid for income taxes – net of refunds

 

34,964

 

 

 

70,831

 

 

 

25,537

 

Non-cash investing and financing activities:

 

 

 

 

 

Capital expenditures incurred but not paid

 

8,016

 

 

 

6,150

 

 

 

6,260

 

Liability for contingent performance based payments

 

(847

)

 

 

610

 

 

 

227

 

Shares of common stock repurchased but not settled

 

911

 

 

 

2,112

 

 

 

 

Operating lease right of use assets recognized at ASC 842 transition

 

 

 

 

 

 

 

111,298

 

Operating lease liabilities recognized at ASC 842 transition

 

 

 

 

 

 

 

115,376

 

Operating lease right of use assets recognized after ASC 842 transition

 

70,794

 

 

 

90,799

 

 

 

39,605

 

Use of Non-GAAP Financial Measures

We report our financial results in accordance with accounting principles generally accepted in the United States (GAAP). However, to supplement the financial results prepared in accordance with GAAP, we use non-GAAP financial measures including adjusted EBITDA, organic sales, and non-GAAP net income and diluted net income per share.

Management believes these non-GAAP financial measures that exclude the impact of specific items (described below) may be useful to investors in their assessment of our ongoing operating performance and provide additional meaningful comparisons between current results and results in prior operating periods.

Adjusted EBITDA is defined by us as income before income tax, net other expense, net interest expense and depreciation and amortization and stock-based compensation expense (or operating income plus depreciation and amortization expense and stock-based compensation expense). We present adjusted EBITDA because we believe that adjusted EBITDA is a useful supplemental measure in evaluating the cash flows and performance of our business and provides greater transparency into our results of operations. Adjusted EBITDA is used by our management to perform such evaluation. Adjusted EBITDA should not be considered in isolation or as a substitute for cash flow from operations, income from operations or other income statement measures prepared in accordance with GAAP. We believe that adjusted EBITDA is frequently used by investors, securities analysts and other interested parties in their evaluation of companies, many of which present adjusted EBITDA when reporting their results. Other companies may calculate adjusted EBITDA differently and it may not be comparable.

We have also provided organic net sales, a non-GAAP measure that excludes the impact of businesses purchased or exited in the prior 12 months, because we believe it permits investors to better understand the performance of our historical business without the impact of recent acquisitions or dispositions.

The reconciliations of these non-GAAP measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are shown in the tables below. We believe that the non-GAAP financial measures provide useful information to investors and other users of our financial statements, by allowing for greater transparency in the review of our financial and operating performance. Management also uses these non-GAAP financial measures in making financial, operating and planning decisions and in evaluating our performance, and we believe these measures similarly may be useful to investors in evaluating our financial and operating performance and the trends in our business from management's point of view. While our management believes that non-GAAP measurements are useful supplemental information, such adjusted results are not intended to replace our GAAP financial results and should be read in conjunction with those GAAP results.

Non-GAAP financial measures reflect adjustments based on the following items:

  • Incremental expenses from note redemption and issuance: we have excluded the impact of the incremental expenses incurred from the note redemption and issuance as they represent an infrequent transaction that occurs in limited circumstances that impacts the comparability between operating periods. We believe the adjustment of these expenses supplements the GAAP information with a measure that may be used to assess the sustainability of our operating performance.
  • Loss on sale of business: we have excluded the impact of the loss on the sale of a business as it represents an infrequent transaction that occurs in limited circumstances that impacts the comparability between operating periods. We believe the adjustment of this loss supplements the GAAP information with a measure that may be used to assess the sustainability of our operating performance.

From time to time in the future, there may be other items that we may exclude if we believe that doing so is consistent with the goal of providing useful information to investors and management.

The non-GAAP adjustments made reflect the following:

(1)

During the first quarter of fiscal 2021, we issued $500 aggregate principal amount of 4.125% senior notes due October 2030. We used a portion of the proceeds to redeem all of our outstanding 6.125% senior notes due 2023. As a result of our redemption of the 2023 Notes, we incurred incremental expenses of approximately $10.0 million, comprised of a call premium payment of $6.1 million, overlapping interest expense of approximately $1.4 million and a $2.5 million non-cash charge for the write-off of unamortized financing costs in interest expense. These amounts are included in interest expense in the consolidated statements of operations.

(2)

During the first quarter of fiscal 2021, we recognized a loss of $2.6 million, included in selling, general and administrative expense in the consolidated statement of operations, from the sale of our Breeder's Choice business unit after concluding it was not a strategic business for our Pet segment.

 

 

GAAP to Non-GAAP Reconciliation

For the Fiscal Year Ended

 

 

(in thousands, except per share amounts)

Net Income and Diluted Net Income Per Share Reconciliation

 

September 24, 2022

 

September 25, 2021

GAAP net income attributable to Central Garden & Pet Company

 

$

152,152

 

$

151,746

 

Incremental expenses from note redemption and issuance

(1)

 

 

 

9,952

 

Loss on sale of business

(2)

 

 

 

2,611

 

Tax effect of incremental redemption expenses and loss on sale

 

 

 

 

(2,711

)

Non-GAAP net income attributable to Central Garden & Pet Company

 

$

152,152

 

$

161,598

 

GAAP diluted net income per share

 

$

2.80

 

$

2.75

 

Non-GAAP diluted net income per share

 

$

2.80

 

$

2.92

 

Shares used in GAAP and non-GAAP diluted net income per share calculation

 

 

54,425

 

 

55,248

 

Organic Net Sales Reconciliation

We have provided organic net sales, a non-GAAP measure that excludes the impact of recent acquisitions and dispositions, because we believe it permits investors to better understand the performance of our historical business. We define organic net sales as net sales from our historical business derived by excluding the net sales from businesses acquired or exited in the preceding 12 months. After an acquired business has been part of our consolidated results for 12 months, the change in net sales thereafter is considered part of the increase or decrease in organic net sales.

CONSOLIDATED

 

GAAP to Non-GAAP Reconciliation

For the Fiscal Year Ended September 24, 2022

 

 

Net sales (GAAP)

 

Effect of acquisitions &

divestitures on net sales

 

Net sales organic

 

 

(in millions)

Reported net sales FY 2022

 

$

3,338.6

 

 

$

146.9

 

$

3,191.7

 

Reported net sales FY 2021

 

 

3,303.7

 

 

 

3.9

 

 

3,299.8

 

$ increase (decrease)

 

$

34.9

 

 

$

143.0

 

$

(108.1

)

% increase (decrease)

 

 

1.1

%

 

 

 

 

(3.3

)%

PET

 

GAAP to Non-GAAP Reconciliation

For the Fiscal Year Ended September 24, 2022

 

 

Net sales (GAAP)

 

Effect of acquisitions &

divestitures on net sales

 

Net sales organic

 

 

(in millions)

Reported net sales FY 2022

 

$

1,878.1

 

 

$

 

 

$

1,878.1

 

Reported net sales FY 2021

 

 

1,894.9

 

 

 

3.9

 

 

 

1,891.0

 

$ decrease

 

$

(16.8

)

 

$

(3.9

)

 

$

(12.9

)

% decrease

 

 

(0.9

)%

 

 

 

 

(0.7

)%

GARDEN

 

GAAP to Non-GAAP Reconciliation

For the Fiscal Year Ended September 24, 2022

 

 

Net sales (GAAP)

 

Effect of acquisitions &

divestitures on net sales

 

Net sales organic

 

 

(in millions)

Reported net sales FY 2022

 

$

1,460.5

 

 

$

146.9

 

$

1,313.6

 

Reported net sales FY 2021

 

 

1,408.8

 

 

 

 

 

1,408.8

 

$ increase (decrease)

 

$

51.7

 

 

$

146.9

 

$

(95.2

)

% increase (decrease)

 

 

3.7

%

 

 

 

 

(6.8

)%

Adjusted EBITDA Reconciliation

 

The following is a reconciliation of net income to adjusted EBITDA:

 

 

 

GAAP to non-GAAP Reconciliation

Fiscal Year Ended September 24, 2022

 

 

(in thousands)

Adjusted EBITDA Reconciliation

 

Garden

 

Pet

 

Corp

 

Total

Net income attributable to Central Garden & Pet

 

$

 

$

 

$

 

 

$

152,152

Interest expense, net

 

 

 

 

 

 

 

 

 

57,534

Other expense

 

 

 

 

 

 

 

 

 

3,596

Income tax expense

 

 

 

 

 

 

 

 

 

46,234

Net income attributable to noncontrolling interest

 

 

 

 

 

 

 

 

 

520

Sum of items below operating income

 

 

 

 

 

 

 

 

 

107,884

Income (loss) from operations

 

 

153,956

 

 

208,924

 

 

(102,844

)

 

 

260,036

Depreciation & amortization

 

 

36,583

 

 

38,960

 

 

5,405

 

 

 

80,948

Noncash stock-based compensation

 

 

 

 

 

 

25,817

 

 

 

25,817

Adjusted EBITDA

 

$

190,539

 

$

247,884

 

$

(71,622

)

 

$

366,801

 

 

GAAP to non-GAAP Reconciliation

Fiscal Year Ended September 25, 2021

 

 

(in thousands)

Adjusted EBITDA Reconciliation

 

Garden

 

Pet

 

Corp

 

Total

Net income attributable to Central Garden & Pet

 

$

 

$

 

$

 

 

$

151,746

Interest expense, net

 

 

 

 

 

 

 

 

 

58,182

Other expense

 

 

 

 

 

 

 

 

 

1,506

Income tax expense

 

 

 

 

 

 

 

 

 

42,035

Net income attributable to noncontrolling interest

 

 

 

 

 

 

 

 

 

1,027

Sum of items below operating income

 

 

 

 

 

 

 

 

 

102,750

Income (loss) from operations

 

 

138,755

 

 

208,201

 

 

(92,460

)

 

 

254,496

Depreciation & amortization

 

 

33,050

 

 

36,952

 

 

4,725

 

 

 

74,727

Noncash stock-based compensation

 

 

 

 

 

 

23,127

 

 

 

23,127

Adjusted EBITDA

 

$

171,805

 

$

245,153

 

$

(64,608

)

 

$

352,350

 

GAAP to non-GAAP Reconciliation

Quarter Ended September 24, 2022

 

 

(in thousands)

Adjusted EBITDA Reconciliation

 

Garden

 

Pet

 

Corp

 

Total

 

 

 

 

 

 

 

 

 

Net loss attributable to Central Garden & Pet

 

$

 

$

 

$

 

 

$

(1,990

)

Interest expense, net

 

 

 

 

 

 

 

 

 

14,089

 

Other expense

 

 

 

 

 

 

 

 

 

2,259

 

Income tax benefit

 

 

 

 

 

 

 

 

 

(1,085

)

Net loss attributable to noncontrolling interest

 

 

 

 

 

 

 

 

 

(375

)

Sum of items below operating income

 

 

 

 

 

 

 

 

 

14,888

 

Income (loss) from operations

 

 

1,824

 

 

40,412

 

 

(29,338

)

 

 

12,898

 

Depreciation & amortization

 

 

10,127

 

 

10,081

 

 

2,407

 

 

 

22,615

 

Noncash stock-based compensation

 

 

 

 

 

 

6,938

 

 

 

6,938

 

Adjusted EBITDA

 

$

11,951

 

$

50,493

 

$

(19,993

)

 

$

42,451

 

 

 

GAAP to non-GAAP Reconciliation

Quarter Ended September 25, 2021

 

 

(in thousands)

Adjusted EBITDA Reconciliation

 

Garden

 

Pet

 

Corp

 

Total

Net loss attributable to Central Garden & Pet

 

$

 

$

 

$

 

 

$

(3,007

)

Interest expense, net

 

 

 

 

 

 

 

 

 

14,176

 

Other expense

 

 

 

 

 

 

 

 

 

1,876

 

Income tax benefit

 

 

 

 

 

 

 

 

 

(3,225

)

Net loss attributable to noncontrolling interest

 

 

 

 

 

 

 

 

 

(215

)

Sum of items below operating income

 

 

 

 

 

 

 

 

 

12,612

 

Income (loss) from operations

 

 

1,105

 

 

31,597

 

 

(23,097

)

 

 

9,605

 

Depreciation & amortization

 

 

10,800

 

 

10,025

 

 

1,143

 

 

 

21,968

 

Noncash stock-based compensation

 

 

 

 

 

 

6,087

 

 

 

6,087

 

Adjusted EBITDA

 

$

11,905

 

$

41,622

 

$

(15,867

)

 

$

37,660

 

 

Contacts

Investor Relations Contact:

Friederike Edelmann

VP of Investor Relations

(925) 412 6726

fedelmann@central.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.